An open-label study of the effect of Xeloda [capecitabine] on time to disease progression in patients with metastatic or locally advanced breast cancer previously treated with an anthracycline and a taxane.
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2010
At a glance
- Drugs Capecitabine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Roche
- 23 Feb 2010 Status changed from active, no longer recruiting to completed as reported by Roche record.
- 01 Jun 2006 New trial record.